Do you want to read an article? Please log in or register.
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial
ARDS
COVID-19
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)